Skip to content
Biodatica
Start free

Investigator

Song Li

UNIVERSITY OF PITTSBURGH AT PITTSBURGH · funded by NCI, NINDS

Companies
2

Resolved onto their grants.

Grants
10

Federal awards on file.

Non-dilutive funding
$5.0M

Summed across those awards.

First award
May 1, 2022

Latest Jan 9, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Targeting iRhom to Improve Colon Cancer Immunochemotherapy

    $547k

    Jan 9, 2025NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11019635 (opens the source filing in a new tab)

  2. R01

    Targeting iRhom to Improve Colon Cancer Immunochemotherapy

    $547k

    Jan 9, 2025NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11257677 (opens the source filing in a new tab)

  3. R01

    Mechanopriming for cell engineering

    $526k

    Jun 15, 2023NINDSUNIVERSITY OF CALIFORNIA LOS ANGELESNIH RePORTER · 11124064 (opens the source filing in a new tab)

  4. R01

    Mechanopriming for cell engineering

    $534k

    Jun 15, 2023NINDSUNIVERSITY OF CALIFORNIA LOS ANGELESNIH RePORTER · 11357570 (opens the source filing in a new tab)

  5. R01

    Nanoparticles-mediated combination therapy for breast cancer

    $502k

    May 1, 2023NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11066485 (opens the source filing in a new tab)

  6. R01

    Nanoparticles-mediated combination therapy for breast cancer

    $502k

    May 1, 2023NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11306616 (opens the source filing in a new tab)

  7. R01

    Combination Therapy for Pancreatic Cancer

    $473k

    Apr 1, 2023NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11053633 (opens the source filing in a new tab)

  8. R01

    Combination Therapy for Pancreatic Cancer

    $473k

    Apr 1, 2023NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11294312 (opens the source filing in a new tab)

  9. R01

    Multimodal wireless electrical stimulation for tissue regeneration

    $472k

    May 1, 2022NINDSUNIVERSITY OF CALIFORNIA LOS ANGELESNIH RePORTER · 11086134 (opens the source filing in a new tab)

  10. R01

    Multimodal wireless electrical stimulation for tissue regeneration

    $472k

    May 1, 2022NINDSUNIVERSITY OF CALIFORNIA LOS ANGELESNIH RePORTER · 11389326 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources